A new study finds children and teens with obesity or diabetes who take GLP-1 weight-loss medications experience significant improvements in many cardiometabolic risk factors, but long-term safety questions remain.
Our commitment to patient care and health is priority one here at IV Stat.
We believe in the value of providing personalized service and quality products.
2025 © All Rights Reserved. Privacy Policy